[Unruptured brain aneurysms: when to screen and when to treat?].
Standard
[Unruptured brain aneurysms: when to screen and when to treat?]. / Fiehler, Jens.
In: ROFO-FORTSCHR RONTG, Vol. 184, No. 2, 2, 2012, p. 97-104.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Unruptured brain aneurysms: when to screen and when to treat?].
AU - Fiehler, Jens
PY - 2012
Y1 - 2012
N2 - The detection rate of intracranial aneurysms has increased with the improved availability of non-invasive imaging methods. Moreover, persons who have relatives with intracranial aneurysms increasingly demand imaging to rule out aneurysms. To deal with these problems, radiologists require basic knowledge regarding the detection and treatment of unruptured intracranial aneurysms. The prevalence of aneurysms in the normal population is 2?-?3?%. It increases to 4?-?10?% in persons with one relative with an aneurysm and to about 20?% in persons with two relatives with an aneurysm. The average natural rupture risk is estimated to be 5?% within 5 years of detection. In the individual case it depends on several variables that are discussed here. According to the literature, the risk of endovascular aneurysm treatment is about 5?%. On the basis of these data, the benefit of MRA screening needs to be discussed individually with the patient.
AB - The detection rate of intracranial aneurysms has increased with the improved availability of non-invasive imaging methods. Moreover, persons who have relatives with intracranial aneurysms increasingly demand imaging to rule out aneurysms. To deal with these problems, radiologists require basic knowledge regarding the detection and treatment of unruptured intracranial aneurysms. The prevalence of aneurysms in the normal population is 2?-?3?%. It increases to 4?-?10?% in persons with one relative with an aneurysm and to about 20?% in persons with two relatives with an aneurysm. The average natural rupture risk is estimated to be 5?% within 5 years of detection. In the individual case it depends on several variables that are discussed here. According to the literature, the risk of endovascular aneurysm treatment is about 5?%. On the basis of these data, the benefit of MRA screening needs to be discussed individually with the patient.
KW - Randomized Controlled Trials as Topic
KW - Treatment Outcome
KW - Sensitivity and Specificity
KW - Prognosis
KW - Follow-Up Studies
KW - Image Processing, Computer-Assisted
KW - Imaging, Three-Dimensional
KW - Risk
KW - Incidental Findings
KW - Mass Screening
KW - Surgical Instruments
KW - Embolization, Therapeutic
KW - Genetic Predisposition to Disease/genetics
KW - Magnetic Resonance Angiography
KW - Aneurysm, Ruptured/diagnosis/genetics/therapy
KW - Intracranial Aneurysm/diagnosis/genetics/therapy
KW - Subarachnoid Hemorrhage/diagnosis/genetics/therapy
KW - Randomized Controlled Trials as Topic
KW - Treatment Outcome
KW - Sensitivity and Specificity
KW - Prognosis
KW - Follow-Up Studies
KW - Image Processing, Computer-Assisted
KW - Imaging, Three-Dimensional
KW - Risk
KW - Incidental Findings
KW - Mass Screening
KW - Surgical Instruments
KW - Embolization, Therapeutic
KW - Genetic Predisposition to Disease/genetics
KW - Magnetic Resonance Angiography
KW - Aneurysm, Ruptured/diagnosis/genetics/therapy
KW - Intracranial Aneurysm/diagnosis/genetics/therapy
KW - Subarachnoid Hemorrhage/diagnosis/genetics/therapy
M3 - SCORING: Zeitschriftenaufsatz
VL - 184
SP - 97
EP - 104
JO - ROFO-FORTSCHR RONTG
JF - ROFO-FORTSCHR RONTG
SN - 1438-9029
IS - 2
M1 - 2
ER -
